Related Experiment Video
Updated: Mar 31, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Impact of Tobacco Smoke and Nicotine Exposure on Lung Development
Kevin Gibbs1, Joseph M Collaco2, Sharon A McGrath-Morrow2
1Division of Pulmonary and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, MD.
Insights
Prenatal and postnatal tobacco and nicotine exposure harms lung development and immune responses in children, increasing risks for asthma and infections. Recent research highlights genetic and epigenetic factors influencing these long-term respiratory health outcomes.
Area of Science:
- Pediatric Respiratory Medicine
- Environmental Health Sciences
- Developmental Toxicology
Background:
- Prenatal and postnatal exposure to tobacco smoke and nicotine negatively impacts lung development and immune function.
- This exposure is linked to increased wheezing, viral infection susceptibility, and asthma symptoms in children.
- Approximately 10% of US pregnancies involve in utero tobacco/nicotine exposure, posing significant health risks to neonates.
Purpose of the Study:
- To review recent discoveries (last 5 years) on lung development and tobacco/nicotine exposure.
- To focus on the impact of prenatal exposure on lung development, particularly nicotinic acetylcholine receptors.
- To examine the association between exposure and augmented infection risk, immune skewing, and allergic phenotypes.
Main Methods:
- Review of recent scientific literature (last 5 years) on tobacco/nicotine exposure and lung development.
- Analysis of studies investigating effects on respiratory function, immune response, and asthma development.
- Examination of genomic and epigenetic factors influencing long-term respiratory health.
Main Results:
- Prenatal and postnatal exposure diminishes lung function and alters respiratory chemoreception in neonates.
- Exposure is associated with a T-helper type 2 immune bias, increasing allergy and asthma risk.
- Genomic and epigenetic factors, like DNA methylation changes, are identified as potential risk modifiers.
Conclusions:
- Tobacco and nicotine exposure during critical developmental periods has lasting adverse effects on respiratory health.
- Understanding genetic and epigenetic influences is crucial for mitigating risks associated with early-life exposure.
- Secondhand smoke and nicotine exposure in childhood contribute to significant respiratory morbidities.
Abstract:
Tobacco smoke and nicotine exposure during prenatal and postnatal life can impair lung development, alter the immune response to viral infections, and increase the prevalence of wheezing during childhood. The following review examines recent discoveries in the fields of lung development and tobacco and nicotine exposure, emphasizing studies published within the last 5 years. In utero tobacco and nicotine exposure remains common, occurring in approximately 10% of pregnancies within the United States. Exposed neonates are at increased risk for diminished lung function, altered central and peripheral respiratory chemoreception, and increased asthma symptoms throughout childhood. Recently, genomic and epigenetic risk factors, such as alterations in DNA methylation, have been identified that may influence the risk for long-term disease. This review examines the impact of prenatal tobacco and nicotine exposure on lung development with a particular focus on nicotinic acetylcholine receptors. In addition, this review examines the role of prenatal and postnatal tobacco smoke and nicotine exposure and its association with augmenting infection risk, skewing the immune response toward a T-helper type 2 bias and increasing risk for developing an allergic phenotype and asthmalike symptoms during childhood. Finally, this review outlines the respiratory morbidities associated with childhood secondhand smoke and nicotine exposure and examines genetic and epigenetic modifiers that may influence respiratory health in infants and children exposed to in utero or postnatal tobacco smoke.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Statistical Methods for Analyzing Epidemiological Data

